BBPvsPSCHETF Comparison
VS
Virtus LifeSci Biotech Products ETF (BBP) belongs to the Tomorrow's Treatments segment. Invesco S&P SmallCap Health Care ETF (PSCH) is part of the US Health Care segment. Both ETFs have the same top 1 sector exposures: Healthcare. BBP is more expensive with a Total Expense Ratio (TER) of 0.34%, versus 0.29% for PSCH. BBP is up 29.59% year-to-date (YTD) with +$61M in YTD flows. PSCH performs worse with 20.58% YTD performance, and +$7M in YTD flows. Run a side-by-side ETF comparison of BBP and PSCH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
BBP vs PSCH performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/11/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BBP PSCH | +1.58%-3.91% | +19.06%+12.71% | +29.59%+20.58% | +46.60%+31.06% | +94.97%+34.64% | +99.54%-14.13% |
| Flows | BBP PSCH | +$16M+$14M | +$31M+$25M | +$61M+$7M | +$72M+$2M | +$78M-$109M | +$71M-$207M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BBP PSCH | +25.64%+15.88% | +25.15%+19.61% | +24.71%+21.82% | +26.61%+22.87% |
| Max drawdown | BBP PSCH | -9.34%-5.28% | -9.59%-15.36% | -25.54%-22.80% | -37.61%-45.76% |
| Max drawdown duration | BBP PSCH | 39d22d | 48d168d | 292d488d | 586d1767d |
Trading data
BBP | PSCH | |
Last sale 9/11/2026 at 1:30 PM | $103.46 | $52.95 |
| Previous close 09/10/2026 | $103.47 | $53.11 |
| Consolidated volume 09/10/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of August 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
BBP | PSCH | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 9/11/2026 at 1:30 PM
Live
Closed
BBP | PSCH | |
|---|---|---|
| Last price | $103.46 | $52.95 |
| 1D performance | -0.01% | -0.30% |
| AuM | $124.03 M | $179.68 M |
| E/R | 0.34% | 0.29% |
Characteristics
BBP | PSCH | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | VIRTUS Investment Partners | Invesco |
| Benchmark | LifeSci Biotechnology Products Index | S&P SmallCap 600 Capped Health Care Index |
| N° of holdings | 66 | 69 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 16, 2014 | April 7, 2010 |
| ESG | No | No |
Advertisement
Exposure
Countries
BBP
USA
86.5%
Other
13.5%
PSCH
USA
95.04%
Other
4.96%
Sectors
BBP
Healthcare
98.2%
Other
1.8%
PSCH
Healthcare
100%
Other
0%
Advertisement
Diversification
BBP
Total weight of top 15 holdings out of 15
26.78%
PSCH
Total weight of top 15 holdings out of 15
48.1%
Top 15 holdings
Data as of July 31, 2026
BBP
Crinetics Pharmaceuticals, Inc.
3.24%
Verastem, Inc.
1.98%
Nuvation Bio, Inc.
1.80%
Omeros Corp.
1.73%
Geron Corp.
1.72%
BridgeBio Pharma, Inc.
1.68%
Agios Pharmaceuticals, Inc.
1.67%
Protagonist Therapeutics, Inc.
1.65%
BeOne Medicines Ltd.
1.64%
Kiniksa Pharmaceuticals International Plc
1.63%
Precigen, Inc.
1.62%
Xeris Biopharma Holdings, Inc.
1.61%
ACADIA Pharmaceuticals, Inc.
1.60%
Iovance Biotherapeutics, Inc.
1.60%
Rhythm Pharmaceuticals, Inc.
1.60%
PSCH
Glaukos Corp.
4.96%
Corcept Therapeutics, Inc.
4.64%
Alkermes Plc
4.21%
Protagonist Therapeutics, Inc.
4.20%
TG Therapeutics, Inc.
3.68%
PTC Therapeutics, Inc.
3.23%
Liquidia Corp.
3.19%
Teleflex, Inc.
3.11%
Ligand Pharmaceuticals, Inc.
3.01%
Indivior Pharmaceuticals, Inc.
2.55%
Merit Medical Systems, Inc.
2.52%
RadNet, Inc.
2.34%
Veracyte, Inc.
2.32%
ICU Medical, Inc.
2.17%
Concentra Group Holdings Parent, Inc.
1.96%
Frequently asked questions about BBP and PSCH
How have the BBP and PSCH ETFs performed in 2026?
As of September 11, 2026, BBP is up 29.59% year-to-date (YTD), while PSCH has returned 20.58%. That puts BBP better performer ahead so far this year.
Which ETF is attracting more investor money: BBP or PSCH?
Year-to-date, the BBP ETF saw +$61M in flows, compared to +$7M for PSCH.
Which ETF is more volatile: BBP or PSCH?
Over the past year, BBP had a volatility of 25.15%, while PSCH experienced 19.61%.
Which ETF is bigger: BBP or PSCH?
As of September 11, 2026, BBP holds $124.03 M in assets under management (AUM), while PSCH manages $179.68 M.
What sectors do the BBP and PSCH ETFs invest in?
BBP leans toward sectors like Healthcare. Meanwhile, PSCH focuses on Healthcare.
What are the top holdings of the BBP ETF and PSCH ETF?
BBP top holdings include Crinetics Pharmaceuticals, Inc., Verastem, Inc. and Nuvation Bio, Inc.. PSCH holds in its top three: Glaukos Corp., Corcept Therapeutics, Inc. and Alkermes Plc.
Which ETF is more diversified: BBP or PSCH?
BBP holds 66 securities with 26.78% of its assets in the top 15. PSCH has 69 securities and a top 15 weight of 48.1%.
Advertisement
Advertisement
